A Randomized, Open-label, Active-controlled, Parallel-group Study to Investigate the Platelet Inhibition of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease and Type 2 Diabetes Mellitus After Recent Elective Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms PLATIDE-PCI
- 03 Jan 2017 Planned End Date changed from 1 May 2017 to 1 Apr 2018.
- 03 Jan 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Mar 2018.
- 03 Jan 2017 Status changed from not yet recruiting to recruiting.